<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Merck.com</provider_name><provider_url>https://www.merck.com</provider_url><author_name>Merck.com</author_name><author_url>https://www.merck.com</author_url><title>Merck Animal Health to Acquire Vence - Merck.com</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="DtnsHGFbfO"&gt;&lt;a href="https://www.merck.com/news/merck-animal-health-to-acquire-vence/"&gt;Merck Animal Health to Acquire Vence&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.merck.com/news/merck-animal-health-to-acquire-vence/embed/#?secret=DtnsHGFbfO" width="600" height="338" title="&#x201C;Merck Animal Health to Acquire Vence&#x201D; &#x2014; Merck.com" data-secret="DtnsHGFbfO" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/*! This file is auto-generated */
!function(c,d){"use strict";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},!c.wp.receiveEmbedMessage)if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){for(var r,a,i,s=d.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=d.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=0;o&lt;n.length;o++)n[o].style.display="none";for(o=0;o&lt;s.length;o++)if(r=s[o],e.source===r.contentWindow){if(r.removeAttribute("style"),"height"===t.message){if(1e3&lt;(i=parseInt(t.value,10)))i=1e3;else if(~~i&lt;200)i=200;r.height=i}if("link"===t.message)if(a=d.createElement("a"),i=d.createElement("a"),a.href=r.getAttribute("src"),i.href=t.value,i.host===a.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener("message",c.wp.receiveEmbedMessage,!1),d.addEventListener("DOMContentLoaded",t,!1),c.addEventListener("load",t,!1);function t(){if(!o){o=!0;for(var e,t,r,a=-1!==navigator.appVersion.indexOf("MSIE 10"),i=!!navigator.userAgent.match(/Trident.*rv:11\./),s=d.querySelectorAll("iframe.wp-embedded-content"),n=0;n&lt;s.length;n++){if(!(r=(t=s[n]).getAttribute("data-secret")))r=Math.random().toString(36).substr(2,10),t.src+="#?secret="+r,t.setAttribute("data-secret",r);if(a||i)(e=t.cloneNode(!0)).removeAttribute("security"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:"ready",secret:r},"*")}}}}(window,document);
&lt;/script&gt;
</html><description>Virtual fencing system provides advanced technology to cattle producers and ranchers to manage natural resources more effectively Complements Merck Animal Health&#x2019;s broad portfolio of veterinary pharmaceuticals, vaccines and animal intelligence solutions MADISON, N.J., Sept. 22, 2022 &#x2013; Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck &amp; Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today that it has signed a definitive agreement under which Merck Animal Health will acquire Vence from its founders and shareholders. Vence is an innovator in virtual fencing for rotational grazing and livestock management. The acquisition is expected to be completed in the third quarter of 2022, subject to customary closing conditions. Specific terms of the agreement were not disclosed. Vence, a privately held company, provides enhanced technology for producers and ranchers to track, monitor and manage the movement of cattle through</description><thumbnail_url>https://www.merck.com/wp-content/uploads/sites/5/2022/03/Merck.png</thumbnail_url><thumbnail_width>3056</thumbnail_width><thumbnail_height>1380</thumbnail_height></oembed>
